Search
forResearch 10 of 1000+
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- New insights into molecular signaling pathways and current advancements in prostate cancer diagnostics & therapeutics
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Redefining hormone resistance in prostate cancer
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- Characteristics of flutamide action on prostatic and testicular functions in the rat
- Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer
- Low-Dose Dimethyl Sulfoxide (DMSO) Suppresses Androgen Receptor (AR) and Its Splice Variant AR-V7 in Castration-Resistant Prostate Cancer (CRPC) Cells
- Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →